On May 16th, the first Sino-Russian Electronic Cigarette Scientific Research Exchange Conference was held in Moscow. The conference was co-hosted by the N.M. Emanuel Biochemical and Physical Research Institute of the Russian Academy of Sciences and 2FIRSTS (2firsts.com). The purpose of the conference was to explore scientific research and cooperation in electronic cigarettes, and to promote in-depth cooperation and communication between China and Russia in the field of electronic cigarette scientific research. Attendees, including scholars and business representatives, engaged in extensive and in-depth discussions on the progress, achievements, and future development direction of electronic cigarette scientific research.
Chinese companies that participated in the exchange meeting include Shenzhen Zhenwei Biotechnology Co. Ltd, Shenzhen Seamild Electronic Technology Co. Ltd, Bengbu Qiwu Electronics Co. Ltd, and Jiaste Electronic Technology (Dongguan) Co. Ltd. The attending companies cover various fields such as manufacturing, e-liquids, brands, and devices, making them typical representatives of "Made in China" and "Chinese brands" in the electronic cigarette industry.
Alexei Vladislavovich Trofimov, the deputy director of the Newman-Nal'chik Institute of Biochemistry and Physics, led a delegation to visit an electronic cigarette research laboratory.
Valery Menshov, a scientist at the Institute of Biochemistry and Physics of the Russian Academy of Sciences, delivered a lecture and shared the institute's latest research findings in the field of electronic cigarettes. He also had an academic exchange with representatives from Chinese companies. The Chinese representatives then presented their own research and development progress in scientific research.
Valery Menchov shared the latest scientific results of electronic cigarettes with representatives from Chinese companies. Image source: 2FIRSTS.
In the presence of entrepreneurs and experts from China and Russia, Aleksey Vladislavovich Trofimov, Deputy Director of the Biochemical and Physical Institute at Newman University of Moscow, representing the Russian Academy of Sciences, and Zhao Tong, co-founder and CEO of Shenzhen 2FIRSTS Technology Co., Ltd., signed a memorandum of understanding to promote joint research efforts in the field of electronic cigarettes between China and Russia. The two parties also plan to undertake concrete activities such as academic exchange, expert visits, and sharing of research results.
2FIRSTS CEO and co-founder Zhao Tong (left) and Aleksandr Vladislavovich Trofimov, Vice Director at the Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences (right), display a memorandum of understanding | Image source: 2FIRSTS About 2FIRSTS:
Shenzhen 2FIRSTS Technology Co., Ltd. is a leading global vaporizer technology media and think tank. The company owns and operates 2firsts.com, a worldwide website available in Chinese, English, and Russian. The platform has created a comprehensive network of information and services covering the globe, with media centers in Shenzhen, Washington, London, Moscow, Indonesia, and elsewhere. By linking the Chinese supply chain of e-cigarettes to the global consumer market, 2FIRSTS has established itself as a major player in the industry.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
